Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.33M Buy
101,755
+23,671
+30% +$852K 0.04% 659
2026
Q1
$2.76M Buy
+78,084
New +$3.18M 0.05% 608
2025
Q3
Sell
-15,084
Closed -$786K 2668
2025
Q2
$786K Buy
+15,084
New +$828K 0.03% 813
2024
Q2
Sell
-12,487
Closed -$1,000K 1953
2024
Q1
$1,000K Buy
+12,487
New +$1.11M 0.13% 161
2023
Q4
Sell
-3,361
Closed -$339K 1673
2023
Q3
$339K Buy
+3,361
New +$386K 0.06% 645

Other funds holding CNMD

XTX Topco's CNMD Position: Q2 2026 in Review

XTX Topco increased its CONMED (CNMD) stake by 30% in Q2 2026, buying an estimated $852K and bringing the position to 101,755 shares worth $3.33M. The position accounts for 0.04% of the portfolio, ranked #659.

XTX Topco first reported a position in CNMD in Q3 2023 and has held it in 5 quarters since. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • XTX Topco held 101,755 shares of CONMED worth $3.33M as of Q2 2026.
  • XTX Topco bought 23,671 CONMED shares in Q2 2026, an estimated $852K.
  • CONMED made up 0.04% of XTX Topco's portfolio in Q2 2026, its #659 holding.
  • XTX Topco first reported a position in CONMED in Q3 2023 and has held it in 5 quarters since.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.